BlackRock Advisors’s MacroGenics MGNX Stock Holding History

BlackRock Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$346K	Sell	16,935 -7,910	-32%	-$199K	﹤0.01%	2432
2016 Q3	$743K	Buy	24,845 +5,180	+26%	+$154K	﹤0.01%	1967
2016 Q2	$531K	Buy	19,665 +4,612	+31%	+$104K	﹤0.01%	2085
2016 Q1	$282K	Sell	15,053 -5,957	-28%	-$113K	﹤0.01%	2374
2015 Q4	$651K	Buy	21,010 +1,287	+7%	+$39.1K	﹤0.01%	1960
2015 Q3	$422K	Sell	19,723 -55,153	-74%	-$1.73M	﹤0.01%	2307
2015 Q2	$2.84M	Buy	74,876 +61,728	+469%	+$2.03M	﹤0.01%	1145
2015 Q1	$412K	Sell	13,148 -72,054	-85%	-$2.44M	﹤0.01%	2229
2014 Q4	$2.99M	Sell	85,202 -52,296	-38%	-$1.3M	﹤0.01%	1084
2014 Q3	$2.87M	Sell	137,498 -45,958	-25%	-$950K	﹤0.01%	1084
2014 Q2	$3.99M	Buy	183,456 +92,699	+102%	+$1.95M	﹤0.01%	1016
2014 Q1	$2.53M	Sell	90,757 -2,035	-2%	-$71.9K	﹤0.01%	1121
2013 Q4	$2.54M	Buy	+92,792	New	+$2.43M	﹤0.01%	1118

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors's MGNX Position: Q4 2016 in Review

BlackRock Advisors reduced its MacroGenics (MGNX) stake by 32% in Q4 2016, selling an estimated $199K and leaving 16,935 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #2432.

BlackRock Advisors first reported a position in MGNX in Q4 2013 and has held it in 13 quarters since. The position peaked at $3.99M in Q2 2014. 131 funds tracked by Wall St. Rank hold MGNX as of Q4 2016.

BlackRock Advisors held 16,935 shares of MacroGenics worth $346K as of Q4 2016.
BlackRock Advisors sold 7,910 MacroGenics shares in Q4 2016, an estimated $199K.
MacroGenics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2432 holding.
BlackRock Advisors first reported a position in MacroGenics in Q4 2013 and has held it in 13 quarters since.
BlackRock Advisors's MacroGenics position peaked at $3.99M in Q2 2014.
131 funds tracked by Wall St. Rank held MacroGenics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.